


























![]()
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day April 22, 2026 10:00 AM EDT
Company Participants
Robert Barrow - CEO & Director
Daniel Karlin - Chief Medical Officer
Matthew Wiley - Chief Commercial Officer
Brandi Roberts - Chief Financial Officer
Conference Call Participants
Brittany Albright
Andrew Penn
Shannon Sarkar
Lin Tsai - Jefferies LLC, Research Division
Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Robert Barrow
CEO & Director
All right. Well, first of all, I want to thank everyone for coming and joining us here today. It's an incredibly exciting time for us. It's an exciting time for our field, and it's great to see everyone here. Many of you, we have spent a lot of time with over the last 5 years, and you've watched not only as we as an organization, but as the entire field has unfolded and has really built to this point where now the promise of what we've been talking about for a long time is coming to fruition and the degree of visibility we're seeing for our field is really taking shape. So we couldn't be more excited to be here with you today. And again, I want to appreciate all of you for coming here and spending your morning and afternoon with us.
Before we get started, forward-looking statements. We'll be saying things about the future that I refer you to all of our filings and the disclaimers, both here and in our SEC filings. We have a great lineup today and great speakers I'll talk about in a second. I'll be brief and then turn it over to Dan, our CMO. We'll have a Q&A session, both with our panel a little bit. And at the end of the event, there's a QR code here at the bottom, right, and it will show up later. Both for folks who are in the room and online, you can ask questions
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。